VarmX raises funds to seek IND approval for VMX-C001

VarmX raises funds to seek IND approval for VMX-C001

Source: 
Pharmaceutical Business Review
snippet: 

Biotechnology company VarmX has raised an additional €30m in a Series B2 financing round to obtain investigational new drug (IND) approval for its lead compound VMX-C001.